About Me

As a partner in our Intellectual Property Group in Singapore and part of the Media, Entertainment & Sports team, I focus on contentious IP matters including IP infringement litigation, patent revocation actions and trade mark oppositions, but also advise clients extensively on non-contentious matters including IP commercialisation, patent and trade mark freedom-to-operate issues and brand protection.

Being not only a lawyer, but also a patent attorney with a Master's degree in Chemical Engineering, I have a keen interest in how things work and a deep appreciation of not only the legal issues but also the technology underlying our clients' businesses. As a former engineer, I understand the difficulty that many clients have with 'lawyer-speak' and strive to deliver practical, commercially-minded advice.

I have acted for international media and technology companies in a range of patent, copyright and trademark disputes both before the Singapore courts and the Registry. I regularly advise clients on patent validity, infringement and freedom-to-operate issues, and on multi-jurisdictional trade mark conflict and enforcement issues. I am also experienced in drafting IP license, R&D collaboration and development agreements.

I participate in various committees including the Association of Singapore Patent Attorneys' Exco, and the Asian Patent Attorneys Association's copyright sub-committee. I am also on the Examination Committee for the Singapore Qualifying Examination for Singapore Patent Attorneys.
Cases
  • Acted for a leading content provider in the Singapore High Court in defending a copyright infringement action brought by a music collecting society, which culminated in a key decision relating to the need for a copyright licence to uplink signals to satellite.
  • Acted for RecordTV, a local media start-up, in the Singapore Court of Appeal in a copyright infringement action involving time shifting of free-to-air broadcasts, and which culminated in a landmark decision dealing with a number of novel points of law.
  • Acted for a number of multinational biopharmaceutical companies including Amgen, Novartis and Celltrion in the Singapore High Court in defending actions brought under the Singapore patent linkage system.
  • Acted for B. Braun, a leading German pharmaceutical and medical device company, in the Singapore High Court in asserting its patent for a medical device.
  • Acted for Global Blue, a leading multi-national company in the payments industry, in the Singapore High Court in defending an infringement claim relating to a patent for a currency conversion system.
  • Represented the Singapore Shipping Association and Association of Marine Industries in the Singapore Patents Registry in revocation actions against patents relating to ballast water management systems to be installed on ships.
Education

Studied

  • Bachelor of Chemical Engineering with First Class Honours from National University of Singapore (NUS)
  • Master of Chemical Engineering from NUS
  • Bachelor of Laws from NUS

Admissions

  • Registered Singapore Patent Attorney (since 2008)
  • Advocate and Solicitor of the Supreme Court of Singapore (since 2010)
Testimonials Carousel Megaphone

Testimonials

Recognised as a 'Next Generation Partner' for Intellectual Property

Legal 500 Singapore, 2024

Recognised as a 'Rising Star' for Intellectual Property

Managing IP - IP Stars 2023 & 2024

Pin-Ping Oh is an up and coming partner with strong knowledge in in relation to IP disputes matters…very responsive and able to give a quick, accurate and efficient response when needed.

Legal 500 EMEA, 2023

Latest insights

More Insights
electronic fingerprint

Embracing AI & Wellness – Where does the buck stop when AI goes wrong?

Sep 04 2024

Read More
Curiosity line pink background

Legislation Update - Changes to patent linkage system in Singapore

Aug 08 2024

Read More

Preliminary injunctions: what approach to liability is taken across the globe?

Apr 30 2024

Read More

News & Deals

More News & Deals

News

Bird & Bird ATMD wins trade mark and passing off action for pharmaceutical giant, Allergan Inc.

Jul 28 2016

Read More

What's on TwoBirds TV?

More Videos